Pharmafile - Research and Development News
Idorsia has announced that it has submitted a new drug application (NDA) to the FDA in hopes of gaining approval for aprocitentan; its novel and...
AlzeCure, a pharma company who focuses on its portfolio of small molecule candidate drugs for central nervous system (CNS) diseases, working on both...
The University of Plymouth has co-authored a new study, published in The Lancet, which shows how an asthma drug, commercially known as Relvar Ellipta...
The FDA has approved Cytalux (pafolacianine) to be used in lung cancer surgery: the targeted imaging agent binds to cancerous tissues, glowing under...
The Center for Disease Control and Prevention (CDC) has given researchers at Washington University School of Medicine in St Louis, US a $12.5m grant...
Biotech company Guardant Health has announced that its blood test-based cancer screening technique appears to be effective: the liquid biopsy...
Merck & Co and Moderna have partnered to utilise the mRNA technology used to combat COVID-19, however this time the technology is set to be used...
California, US-based ClearPoint Neuro has recruited the first patient in a clinical trial which will use ClearPoint’s Prism Neuro Laser Therapy...
A recently-developed AI model has been shown to predict ten-year incidences with a similar level of success to the current standard of care. The AI...
Autolus Therapeutic, a clinical-stage biopharmaceutical company, has announced that the phase 2 FELIX clinical trial of obecabtagene autoleucel (obe-...